Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Boot

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1987
Functional studies with anti-CD3 heavy chain isotype switch-variant monoclonal antibodies. Accessory cell-independent induction of interleukin 2 responsiveness in T cells by epsilon-anti-CD3R A van Lier, J H Boot, A J Verhoeven, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 18, 2014
A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancerD Hompes, A Aalbers, H Boot, et al.
The Journal of Pathology|March 10, 2001
Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphomaD de Jong, F Vyth-Dreese, T Dellemijn, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 21, 2017
Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPECW J van Eden, N F M Kok, K Woensdregt, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 18, 2014
Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapyA M J Kuijpers, A M Mehta, A G J Aalbers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Perioperative systemic chemotherapy in peritoneal carcinomatosis of lymph node positive colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapyA M Kuijpers, A M Mehta, H Boot, et al.
Critical Reviews in Oncology/Hematology|April 30, 2015
Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancerH J Braam, J H Schellens, H Boot, et al.
The Netherlands Journal of Medicine|May 17, 2006
Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinomaS Corporaal, W M Smit, M G V M Russel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 18, 2010
Quality-of-care indicators for oesophageal cancer surgery: A reviewE F W Courrech Staal, M W J M Wouters, H Boot, et al.
Acta Oncologica (Stockholm, Sweden)|January 20, 2017
Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patientsJ J M Kwakman, A Baars, H Boot, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1987
Functional studies with anti-CD3 heavy chain isotype switch-variant monoclonal antibodies. Accessory cell-independent induction of interleukin 2 responsiveness in T cells by epsilon-anti-CD3R A van Lier, J H Boot, A J Verhoeven, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 18, 2014
A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancerD Hompes, A Aalbers, H Boot, et al.
The Journal of Pathology|March 10, 2001
Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphomaD de Jong, F Vyth-Dreese, T Dellemijn, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 21, 2017
Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPECW J van Eden, N F M Kok, K Woensdregt, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 18, 2014
Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapyA M J Kuijpers, A M Mehta, A G J Aalbers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Perioperative systemic chemotherapy in peritoneal carcinomatosis of lymph node positive colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapyA M Kuijpers, A M Mehta, H Boot, et al.
Critical Reviews in Oncology/Hematology|April 30, 2015
Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancerH J Braam, J H Schellens, H Boot, et al.
The Netherlands Journal of Medicine|May 17, 2006
Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinomaS Corporaal, W M Smit, M G V M Russel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 18, 2010
Quality-of-care indicators for oesophageal cancer surgery: A reviewE F W Courrech Staal, M W J M Wouters, H Boot, et al.
Acta Oncologica (Stockholm, Sweden)|January 20, 2017
Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patientsJ J M Kwakman, A Baars, H Boot, et al.
Pageof 13